ITRM logo

Iterum Therapeutics (ITRM) Cash From Investing

Annual CFI

$23.34 M
+$9.38 M+67.20%

December 31, 2023

Summary

Performance

1-Year Change

+67.2%

3-Year Change

+212245.45%

5-Year Change

+369.53%

15-Year Change

+173.88%

ITRM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.75%
ITRM annual cash flow from investing activities is higher than 82.75% of companies in Healthcare sector

High & Low

All-time High

$40.10 M
ITRM annual cash flow from investing activities is currently -41.81% below its historical high of $40.10 million

3-Year Low

-$54.59 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ITRM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ITRM next annual earnings announcement has not yet been scheduled

OtherITRMcash flowmetrics:

Annual CFF

$1.03 M
ITRM annual cash flow from financing activities is $1.03 million

Annual CFO

-$39.33 M
ITRM annual cash flow from operations is -$39.33 million

Annual FCF

-$39.34 M
ITRM annual free cash flow is -$39.34 million

Annual CAPEX

-
ITRM annual capital expenditures value is unknown

Quarterly CFI

$5.70 M
+$1.50 M+35.81%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ITRM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.56%
ITRM quarterly cash flow from investing activities is higher than 80.56% of companies in Healthcare sector

High & Low

All-time High

$35.09 M
ITRM quarterly cash flow from investing activities is currently -83.76% below its historical high of $35.09 million

3-Year Low

-$15.86 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ITRM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ITRM next earnings announcement has not yet been scheduled

OtherITRMcash flowmetrics:

Quarterly CFF

$5.43 M
ITRM quarterly cash flow from financing activities is $5.43 million

Quarterly CFO

-$2.67 M
ITRM quarterly cash flow from operations is -$2.67 million

Quarterly FCF

-$2.67 M
ITRM quarterly free cash flow is -$2.67 million

Quarterly CAPEX

-
ITRM quarterly capital expenditures value is unknown

TTM CFI

$30.63 M
+$5.34 M+21.11%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ITRM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.56%
ITRM TTM cash flow from investing activities is higher than 85.56% of companies in Healthcare sector

High & Low

All-time High

$68.85 M
ITRM TTM cash flow from investing activities is currently -55.51% below its historical high of $68.85 million

3-Year Low

-$54.59 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ITRM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ITRM next earnings announcement has not yet been scheduled

OtherITRMcash flowmetrics:

TTM CFF

$13.40 M
ITRM TTM cash flow from financing activities is $13.40 million

TTM CFO

-$35.36 M
ITRM TTM cash flow from operations is -$35.36 million

TTM FCF

-$35.36 M
ITRM TTM free cash flow is -$35.36 million

TTM CAPEX

-
ITRM TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ITRM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+67.2%0.0%0.0%
3 y3 years+10000.0%0.0%0.0%
5 y5 years+369.5%0.0%0.0%

ITRM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+142.7%-64.0%+135.9%at high+156.1%
5 y5-year-41.8%+142.7%-64.0%+116.8%-23.6%+155.6%
alltimeall time-41.8%+142.7%-83.8%+116.8%-55.5%+155.6%

Iterum Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$5.70 M(+35.8%)
$30.63 M(+21.1%)
Jun 2024
-
$4.20 M(-41.8%)
$25.29 M(-0.6%)
Mar 2024
-
$7.21 M(-46.7%)
$25.44 M(+9.0%)
Dec 2023
$23.34 M(+67.2%)
$13.52 M(+3656.4%)
$23.34 M(+64.4%)
Sep 2023
-
$360.00 K(-91.7%)
$14.19 M(-52.2%)
Jun 2023
-
$4.35 M(-14.9%)
$29.68 M(+213.4%)
Mar 2023
-
$5.11 M(+16.6%)
$9.47 M(-32.1%)
Dec 2022
$13.96 M(-125.6%)
$4.38 M(-72.4%)
$13.96 M(+173.0%)
Sep 2022
-
$15.85 M(-199.9%)
$5.11 M(-188.2%)
Jun 2022
-
-$15.86 M(-265.3%)
-$5.80 M(-47.7%)
Mar 2022
-
$9.59 M(-314.8%)
-$11.08 M(-79.7%)
Dec 2021
-$54.59 M(>+9900.0%)
-$4.47 M(-190.5%)
-$54.59 M(+8.9%)
Sep 2021
-
$4.93 M(-123.3%)
-$50.13 M(-9.0%)
Jun 2021
-
-$21.14 M(-37.7%)
-$55.07 M(+62.3%)
Mar 2021
-
-$33.92 M(<-9900.0%)
-$33.93 M(>+9900.0%)
Dec 2020
-$11.00 K
$0.00(-100.0%)
-$11.00 K(-15.4%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$9000.00(+350.0%)
-$13.00 K(-161.9%)
Jun 2020
-
-$2000.00(<-9900.0%)
$21.00 K(-99.6%)
Mar 2020
-
$0.00(-100.0%)
$5.01 M(-87.5%)
Dec 2019
$40.10 M(-563.2%)
-$2000.00(-108.0%)
$40.10 M(-41.8%)
Sep 2019
-
$25.00 K(-99.5%)
$68.85 M(+34.9%)
Jun 2019
-
$4.99 M(-85.8%)
$51.05 M(+199.0%)
Mar 2019
-
$35.09 M(+22.1%)
$17.07 M(-297.2%)
Dec 2018
-$8.66 M(-72.6%)
$28.75 M(-261.7%)
-$8.66 M(-72.0%)
Sep 2018
-
-$17.77 M(-38.7%)
-$30.96 M(+84.1%)
Jun 2018
-
-$28.99 M(-409.8%)
-$16.82 M(-22.5%)
Mar 2018
-
$9.36 M(+45.2%)
-$21.71 M(-31.3%)
Dec 2017
-$31.59 M(<-9900.0%)
$6.45 M(-277.3%)
-$31.59 M(-16.9%)
Sep 2017
-
-$3.64 M(-89.3%)
-$38.03 M(+10.6%)
Jun 2017
-
-$33.88 M(+6440.3%)
-$34.40 M(+6540.3%)
Mar 2017
-
-$518.00 K
-$518.00 K
Dec 2016
$0.00
-
-

FAQ

  • What is Iterum Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Iterum Therapeutics?
  • What is Iterum Therapeutics annual CFI year-on-year change?
  • What is Iterum Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Iterum Therapeutics?
  • What is Iterum Therapeutics quarterly CFI year-on-year change?
  • What is Iterum Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Iterum Therapeutics?
  • What is Iterum Therapeutics TTM CFI year-on-year change?

What is Iterum Therapeutics annual cash flow from investing activities?

The current annual CFI of ITRM is $23.34 M

What is the all time high annual CFI for Iterum Therapeutics?

Iterum Therapeutics all-time high annual cash flow from investing activities is $40.10 M

What is Iterum Therapeutics annual CFI year-on-year change?

Over the past year, ITRM annual cash flow from investing activities has changed by +$9.38 M (+67.20%)

What is Iterum Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ITRM is $5.70 M

What is the all time high quarterly CFI for Iterum Therapeutics?

Iterum Therapeutics all-time high quarterly cash flow from investing activities is $35.09 M

What is Iterum Therapeutics quarterly CFI year-on-year change?

Over the past year, ITRM quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Iterum Therapeutics TTM cash flow from investing activities?

The current TTM CFI of ITRM is $30.63 M

What is the all time high TTM CFI for Iterum Therapeutics?

Iterum Therapeutics all-time high TTM cash flow from investing activities is $68.85 M

What is Iterum Therapeutics TTM CFI year-on-year change?

Over the past year, ITRM TTM cash flow from investing activities has changed by $0.00 (0.00%)